Integrin-linked kinase (ILK) in hematologic malignancies: Bridging molecular mechanisms to therapeutic innovation

Therapy resistance remains a formidable challenge in hematologic malignancies despite significant advances in targeted therapies. This comprehensive review examines integrin-linked kinase (ILK) as a critical molecular hub at the nexus of cell adhesion, signal transduction, and therapy resistance acr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Omer Qutaiba B. Allela, Abdulkareem Shareef, Ashishkumar Kyada, H. Malathi, Laxmidhar Maharana, Dinesh Puri, Harshit Gupta, Djamila Polatova, Hayder Naji Sameer, Ahmed Yaseen, Zainab H. Athab, Mohaned Adil
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Tabriz University of Medical Sciences 2026-04-01
Edice:	BioImpacts
Témata:	integrin-linked kinase hematologic malignancies therapy resistance tumor microenvironment leukemic stem cells
On-line přístup:	https://bi.tbzmed.ac.ir/PDF/bi-16-32638.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!